ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 243 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,045,000 | +56.1% | 22,000 | 0.0% | 1.32% | +48.0% |
| Q3 2021 | $1,310,000 | -12.7% | 22,000 | 0.0% | 0.89% | -0.7% |
| Q2 2021 | $1,500,000 | -1.8% | 22,000 | 0.0% | 0.90% | -1.1% |
| Q1 2021 | $1,527,000 | -9.6% | 22,000 | 0.0% | 0.91% | -6.9% |
| Q4 2020 | $1,690,000 | -48.6% | 22,000 | -50.0% | 0.97% | -11.4% |
| Q3 2020 | $3,290,000 | +137.5% | 44,000 | +100.0% | 1.10% | +31.3% |
| Q2 2020 | $1,385,000 | +49.9% | 22,000 | 0.0% | 0.84% | +2.1% |
| Q1 2020 | $924,000 | -7.5% | 22,000 | 0.0% | 0.82% | +12.9% |
| Q4 2019 | $999,000 | -0.8% | 22,000 | 0.0% | 0.73% | +8.2% |
| Q3 2019 | $1,007,000 | -21.9% | 22,000 | 0.0% | 0.67% | -14.5% |
| Q2 2019 | $1,290,000 | +30.8% | 22,000 | 0.0% | 0.78% | +27.0% |
| Q1 2019 | $986,000 | +15.1% | 22,000 | 0.0% | 0.62% | -23.8% |
| Q4 2018 | $857,000 | -15.3% | 22,000 | 0.0% | 0.81% | +24.2% |
| Q3 2018 | $1,012,000 | -7.2% | 22,000 | -12.0% | 0.65% | -11.9% |
| Q2 2018 | $1,090,000 | +175.9% | 25,000 | +150.0% | 0.74% | +185.0% |
| Q1 2018 | $395,000 | – | 10,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
| PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
| Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
| Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
| DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
| Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
| First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
| Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
| Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
| Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |